TSMC delivered its fifth consecutive record quarter and the market sold the stock anyway. Q2 revenue reached $39.45 billion, up 36% year over year and above the $39.94 billion consensus. Net income rose 77.4% to roughly $21.9 billion, also a beat. Chips at 7-nanometer and below accounted for 77% of wafer revenue, confirming that the advanced-node mix keeps improving. None of that was the story. TSM shares fell more than 4% in premarket trading, and the reason sits entirely in the capital spending line.
The quarter proves demand is not the constraint anymore — capital is. TSMC raised full-year 2026 revenue growth guidance from “30%+” to “slightly above 40%” in USD terms, citing what management called an AI megatrend and a resurgence in CPU consumption alongside accelerator demand as agentic AI workloads scale. That is an unambiguously bullish demand signal. But the company paired it with a capex increase from $52–56 billion to $60–64 billion, a roughly 15% step-up, and disclosed an additional $100 billion commitment to four new US fabs, taking the total US pledge to $265 billion as part of the broader Washington-Taipei deal. The market is repricing TSMC from a beneficiary of AI capex to AI capex itself, and that changes the multiple investors are willing to pay for the same demand story.
TSMC spent $26.8 billion in H1 2026. Hitting the new full-year target requires another $33.2–37.2 billion in H2, or $16.6–18.6 billion per quarter — a 24–39% step-up from the H1 run rate. Roughly 70–80% of the 2026 budget goes to advanced process technologies, about 10% to specialty technologies, and 10–20% to advanced packaging and testing. Free cash flow already fell 17.5% quarter over quarter in Q2, even as operating cash flow hit a record, because capacity spending is now outrunning the cash the business throws off. That is the mechanical reason the stock is trading like a growth-capex story rather than a cash-return story this cycle.
Management reiterated that overseas fab ramp-up will dilute gross margin by 2–3% in the early stages, widening to 3–4% in later stages, as the $265 billion US buildout comes online. Q2 gross margin printed at 67.7%, with a 60.3% operating margin and 55.6% net margin — all strong in absolute terms — but the guidance for Q3 revenue of $44.6–45.8 billion (37% YoY growth) sits alongside an explicit warning that the newer, less-utilized overseas capacity will weigh on profitability before it adds to it. The dilution is not new information, but the larger capex number makes it feel more immediate and more durable than investors had been pricing.
TSM shares were trading near $434 heading into the print, up roughly 40% year to date, with a market cap around $2.2 trillion. Premarket weakness knocked the stock down more than 4% despite the beat. Analyst sentiment remains skewed bullish: consensus price targets cluster in the high-$400s (roughly $487–498 across several trackers), with Susquehanna at the high end near $575 and BofA raising its NT-denominated target to NT$3,100. The base case has the stock resuming its uptrend once the market finishes digesting the capex reset, on the view that record demand ultimately justifies record spending. The bull case is that the agentic AI-driven CPU resurgence management flagged extends the growth runway well past 2026, supporting the Susquehanna-style targets. The bear case is a derating across the AI capex cohort broadly — TSMC’s move mirrors a pattern already visible in Samsung and SK Hynix’s own outsized investment announcements — where the market starts treating heavy capex commitments as a signal of returns risk rather than demand strength. The single data point that will resolve this fastest is H2 free cash flow: whether it stabilizes as capacity comes online or continues compressing as spending outpaces revenue conversion.
Nothing in this print argues against the AI infrastructure thesis. It argues for being selective about where in the value chain that thesis is expressed. TSMC just told the market, in its own numbers, that the next leg of AI capex growth is being funded by TSMC’s cash flow rather than returned to shareholders, and that overseas dilution is now a multi-year, not a one-time, drag. The read-through for equipment and advanced-packaging suppliers sitting upstream of TSMC’s capex — rather than TSM equity itself — is arguably the cleaner way to keep exposure to this print without absorbing the margin and free-cash-flow risk the market just repriced.